Indianapolis, IN, United States of America

Timothy Ivo Richardson


 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Indianapolis, IN (US) (2007 - 2010)
  • Zionsville, IN (US) (2008 - 2021)

Company Filing History:


Years Active: 2007-2021

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Contributions of Timothy Ivo Richardson

Introduction

Timothy Ivo Richardson is a notable inventor based in Indianapolis, IN, renowned for his significant contributions in the field of pharmaceutical innovation. With a total of 11 patents to his name, Richardson has established himself as a key figure in advancing healthcare solutions.

Latest Patents

Richardson's latest inventions focus on compositions that inhibit ROR gamma-t, a crucial target for treating autoimmune diseases. His recent patents include *Compounds useful for inhibiting ROR γt* – which provides novel inhibitors and pharmaceutical compositions, detailed in formula (A) and formula (I). These advancements highlight his commitment to creating effective therapies and improving patient outcomes.

Career Highlights

Working at Eli Lilly and Company, Richardson has played a vital role in their research and development initiatives. His innovative work has not only led to new patent filings but has also contributed to Eli Lilly's reputation as a leader in pharmaceutical innovation.

Collaborations

Throughout his career, Richardson has collaborated with various esteemed professionals, including his coworkers Bryan Hurst Norman and Gregory Lee Durst. These partnerships have fostered a collaborative environment conducive to groundbreaking discoveries and innovations in the pharmaceutical industry.

Conclusion

Timothy Ivo Richardson stands out as an influential inventor whose work continues to shape the future of medicinal treatments. His dedication to innovation, evidenced by his numerous patents and exceptional collaborations, underscores his impact on the industry and showcases the potential for further advancements in pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…